LONDON--(BUSINESS WIRE)--Virion Biotherapeutics announced today the appointments of Vanessa King, PhD, as President & Chief Executive Officer and Isabel Najera, PhD, as Chief Scientific Officer.

Ocean Biomedical, Inc. (NASDAQ: OCEA) announces that its joint venture partner, Virion Therapeutics, has dosed its first patient in the Phase 1b clinical trial of its investigational VRON-0200 ...

Each filovirus virion has one single-stranded molecule of negative-sense RNA. Transcriptional start and termination signals define and conserve genes within the virus, which are linearly arranged.

Philadelphia PA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Virion Therapeutics, LLC, developer of immunotherapies for cancer and chronic infectious diseases that utilize genetically encoded checkpoint ...

PHILADELPHIA, Sept. 26, 2018 /PRNewswire/ -- A new Philadelphia-based start-up, Virion Therapeutics, LLC spun out of The Wistar Institute, will work to advance innovative, immune-based therapies ...

Wistar Institute spinout company Virion Therapeutics raised a $4 million angel round, according to an SEC filing. The immunotherapy company is working on a path to commercialization for a set of ...

Ebola is a serious and deadly virus transmitted by animals and humans. It was initially detected in 1976 in Sudan and the Democratic Republic of Congo. Researchers named the disease after the ...

Ebola virus is a member of the Filoviridae family.First isolated in 1976, 5 subtypes of Ebola virus are now recognized, of which 4 are pathogenic to humans. The Reston subtype infects only primates.

Except for the proportion who were influenza positive (5.4% vs. 12%; P=0.02), patients who received split-virion vaccines (n=204) were similar to those (n=150) who received subunit vaccines.

A phase 1 clinical trial showed that 2 experimental vaccines, 1 against Ebola and 1 against the related Marburg virus, are well-tolerated and produce immunity after a course of 3 shots and a later ...